BE Form 144: 45,000-Share Sale via Morgan Stanley on NYSE
Rhea-AI Filing Summary
Bloom Energy (Form 144) notice reports a proposed sale of 45,000 common shares with an aggregate market value of $1,948,950.00 to be sold on 08/13/2025 on the NYSE through Morgan Stanley Smith Barney LLC.
The shares were acquired on 08/13/2025 by stock option exercise from the issuer and payment was made in cash. The filing lists 233,997,970 shares outstanding. The filer also disclosed two prior common-share sales in May 2025 totaling 4,276 shares for gross proceeds of $84,585.57. The form includes the standard representation about awareness of material nonpublic information and reference to trading-plan disclosures.
Positive
- Full transaction details provided including broker (Morgan Stanley Smith Barney LLC), exchange (NYSE), and exact aggregate market value
- Acquisition method disclosed as a stock option exercise with payment in cash, providing clear provenance of the shares
Negative
- Proposed sale disclosed by the named person of 45,000 common shares with aggregate value $1,948,950.00
- Recent prior sales of 2,780 and 1,496 shares on 05/14/2025 and 05/16/2025 are reported, showing additional dispositions earlier in the year
Insights
TL;DR: Routine Form 144 discloses a proposed sale of 45,000 shares valued at $1.95M, acquired via option exercise and to be sold through Morgan Stanley on NYSE.
The filing documents a proposed sale by the named person of 45,000 common shares with an aggregate market value of $1,948,950.00 and confirms acquisition by stock option exercise on 08/13/2025 with cash payment. It specifies the executing broker and exchange and lists total shares outstanding of 233,997,970. Two small prior sales in May 2025 are included. From a securities-disclosure perspective, this is a standard notice that provides the required transaction and broker details.
TL;DR: Disclosure presents required sale details and the filer’s representation about material nonpublic information and trading-plan disclosure; no other governance actions shown.
The form contains the mandatory representation that the filer is not aware of undisclosed material adverse information and references Rule 10b5-1 plan disclosure instructions but does not show a plan adoption date in the provided content. It also documents prior share sales by the same person on 05/14/2025 and 05/16/2025. This filing meets typical governance transparency requirements by naming the broker, exchange, acquisition method, sale schedule, and past transactions.